Is Prime Therapeutics owned by Blue Cross

Prime Therapeutics is a privately owned pharmacy benefit manager that serves 23 Blue Cross and Blue Shield Plans and more than 28 million members across the US. With a commitment to making health care ...

Prime Therapeutics LLC (Prime ... Prime serves more than 33 million people. It is collectively owned by 19 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those plans.

TipRanks is the most comprehensive data set of sell side analysts and hedge fund managers. TipRanks' multi-award winning platform ranks financial experts based on measured performance and the ...

About Prime Therapeutics Prime Therapeutics LLC (Prime ... Prime serves more than 33 million people. It is collectively owned by 19 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of ...

Chicago, June 24, 2022 (GLOBE NEWSWIRE) -- According to the new market research report "Digital Therapeutics (DTx) Market by Application (Prediabetes, Nutrition, Care, Diabetes, CVD, CNS ...

New York, June 21, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global RNA Therapeutics Growth Opportunities" - https://www ...

98.61% of the stock is owned by institutional investors and hedge funds. Celldex Therapeutics Company Profile ... of the PD-L1/PD-1 pathway to help prime and activate anti-tumor T cell responses ...

98.61% of the stock is owned by institutional investors and hedge funds. Celldex Therapeutics Company Profile ... of the PD-L1/PD-1 pathway to help prime and activate anti-tumor T cell responses ...